- Sharps Technology stock surged 96% after unveiling a $400M Solana-based treasury plan.
- The company will purchase $50M in SOL via a PIPE deal, with equity tied to token performance.
- Despite Wall Street’s skepticism, Sharps bets Solana’s adoption could fuel stronger returns than traditional reserves.
Medical device maker Sharps Technology (STSS) stunned Wall Street on Monday after revealing a bold pivot into digital assets. Its stock exploded nearly 96% intraday, peaking at $14.53 before cooling to close at $12.01—still way above Friday’s $7.40 close. The rally was tied to a $400 million plan to create a Solana-based treasury, a move that jolted both retail traders and analysts.
Building a Treasury on Solana
The company confirmed it signed a letter of intent with the Solana Foundation to acquire $50 million worth of SOL tokens through a PIPE (private investment in public equity) deal. Investors will purchase Sharps’ stock and stapled warrants at $6.50 per unit, with the warrants exercisable at $9.75 over three years. Essentially, the equity is being tied directly to Solana’s performance—a risky but potentially lucrative alignment.
Sharps also appointed Alice Zhang, co-founder of Web3 startup Jambo, as chief investment officer to steer the crypto strategy, while Solana figure James Zhang joined as a strategic adviser. “Global adoption of Solana is accelerating,” Alice Zhang said. “Now’s the time to build a treasury with SOL for long-term success.” The offering is expected to close by August 28, and investors can even use locked or unlocked SOL to fund allocations.
A Growing Trend Among Biotech and Healthcare Firms
Sharps isn’t the first in its industry to pivot toward crypto. In late 2024, Hoth Therapeutics moved $1 million into Bitcoin. Atai Life Sciences followed in March with a $5 million purchase, while 180 Life Sciences went all-in after a 99% stock crash, rebranding as ETHZilla and announcing a $425 million Ether treasury. Sharps’ Solana play is the latest, but certainly one of the largest attempts so far.
Risks and Skepticism Linger
Investor sentiment went wild after the news. On Stocktwits, retail chatter around STSS surged, with sentiment flipping from “bullish” to “extremely bullish” within a single day. But not everyone’s convinced. Charles Schwab analysts cautioned that companies moving big reserves into volatile crypto markets outside their core business model “raise a red flag or two.”
Still, Sharps insists its pivot is strategic. By leaning on Solana’s growing institutional use cases—Visa recently tested its blockchain for global payments—the firm believes a digital asset treasury could outperform traditional reserves over time.
Solana Price Context
SOL traded between $187–$189 Tuesday, down around 10% from the weekend’s $212 peak, though still far above its 2024 lows. The token’s all-time high of $293, set in January, remains in sight if institutional adoption continues to climb.
